Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I.   Moase Elaine H.   Allen Theresa M.  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite

Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-01 ,pp. : 633-642

Bentham Science Publishers

Access to resources Recommend Favorite

A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune response

By Chakraborty Paramita   Das Satyajit   Banerjee Kaushik   Sinha Abhinaba   Roy Susmita   Chatterjee Mitali   Choudhuri Soumitra Kumar  

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 165-175

Informa Healthcare

Access to resources Recommend Favorite

Contribution of Specific Transport Systems to Anthracycline Transport in Tumor and Normal Cells

By  

Current Drug Metabolism, Vol. 2, Iss. 4, 2001-12 ,pp. : 355-366

Bentham Science Publishers

Access to resources Recommend Favorite

pH-sensitive drug-delivery systems for tumor targeting

By He Xi   Li Jianfeng   An Sai   Jiang Chen  

Therapeutic Delivery, Vol. 4, Iss. 12, 2013-12 ,pp. : 1499-1510

Future Science

Access to resources Recommend Favorite